CYP2E1 and obesity due to melanocortin 4 receptor deficiency: Collectively, these findings identify CYP2E1 as a previously unrecognized regulator of obesity-associated metabolic dysfunction and establish Q11 as a promising therapeutic candidate that concurrently suppresses inflammation and reinstates mitochondrial homeostasis.